PTH hormone

Lanske Lab Research Finding Could Influence Treatment of Osteoporosis and Other Diseases

April 17, 2017

Researchers in the Lanske Laboratory at Harvard School of Dental Medicine (HSDM) in collaboration with the Rosen Laboratory at Maine Medical Center have been studying the function of Parathyroid hormone (PTH) beyond its well-known role in maintaining calcium homeostasis in the body. PTH has been approved for treatment of osteoporosis in humans to induce bone formation.


Intini Lab Research Leads to Collaboration with Boston Children's Hospital Surgeons on Potential Treatments for Craniofacial Malformations

April 5, 2017

A recent research finding published in Stem Cell Reports could potentially lead to therapies that address craniofacial malformations in children. Craniofacial malformations are deformities that affect a child’s head and facial bones—disorders such as cleft palate, or craniosynostosis that are present at birth.